Cargando…

Re: Profile of specific antibodies to SARS-CoV-2: The first report

Detalles Bibliográficos
Autores principales:	Zeng, Zhikun, Chen, Liangjun, Pan, Yunbao, Deng, Qiaoling, Ye, Guangming, Li, Yirong, Wang, Xinghuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194903/ https://www.ncbi.nlm.nih.gov/pubmed/32283140 http://dx.doi.org/10.1016/j.jinf.2020.03.052

Ejemplares similares

Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation
por: Ye, Guangming, et al.
Publicado: (2020)

Can routine laboratory tests discriminate SARS‐CoV‐2‐infected pneumonia from other causes of community‐acquired pneumonia?
por: Pan, Yunbao, et al.
Publicado: (2020)

High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study
por: Deng, Qiaoling, et al.
Publicado: (2021)

SARS-CoV-2-specific immune response in COVID-19 convalescent individuals
por: Pan, Yunbao, et al.
Publicado: (2021)

Correction: SARS-CoV-2-specific immune response in COVID-19 convalescent individuals
por: Pan, Yunbao, et al.
Publicado: (2021)

The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis
por: Fu, Yu, et al.
Publicado: (2021)

Environmental contamination of SARS-CoV-2 in healthcare premises
por: Ye, Guangming, et al.
Publicado: (2020)

Profile of specific antibodies to SARS-CoV-2: The first report
por: Xiao, Ai Tang, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign
por: Pan, Yunbao, et al.
Publicado: (2021)

Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey
por: Zhou, Fuling, et al.
Publicado: (2020)

SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
por: Bongiovanni, Marco, et al.
Publicado: (2022)

Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China
por: Luo, Yi, et al.
Publicado: (2020)

The utility of SARS‐CoV‐2 nucleocapsid protein in laboratory diagnosis
por: Li, Xinwei, et al.
Publicado: (2022)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown
por: Tang, Yueting, et al.
Publicado: (2022)

Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay
por: Cacaci, Margherita, et al.
Publicado: (2021)

The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2
por: Li, Tao, et al.
Publicado: (2020)

Development and validation of immune inflammation–based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma
por: Zeng, Xiaojiao, et al.
Publicado: (2020)

Prognostic Value of Clinical Biochemistry-Based Indexes in Nasopharyngeal Carcinoma
por: Zeng, Xiaojiao, et al.
Publicado: (2020)

Analysis of differential gene expression profile identifies novel biomarkers for breast cancer
por: Pan, Yunbao, et al.
Publicado: (2017)

Re: Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2 by Massalha et al.
por: Zeng, Guangting
Publicado: (2022)

Genomic Analysis of the Unusual Staphylococcus aureus ST630 Isolates Harboring WTA Glycosyltransferase Genes tarM and tagN
por: Xiong, Mengyuan, et al.
Publicado: (2022)

Clinical Performance of Nanopore Targeted Sequencing for Diagnosing Infectious Diseases
por: Fu, Yu, et al.
Publicado: (2022)

Evidence of SARS-CoV-2 re-infection with a different genotype
por: Colson, Philippe, et al.
Publicado: (2021)

Does SARS-CoV-2 re-infection depend on virus variant?
por: Gautret, Philippe, et al.
Publicado: (2021)

Profile of specific antibodies to the SARS-CoV-2
por: Mou, Danlei, et al.
Publicado: (2021)

Re-appearance of the SARS-CoV-2 virus nucleic acid in patients recovering from COVID-19
por: Wang, Liang, et al.
Publicado: (2020)

COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes
por: Zeng, Xiaojiao, et al.
Publicado: (2021)

Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus
por: Shang, Yufeng, et al.
Publicado: (2021)

Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study
por: Atti, A., et al.
Publicado: (2022)

SARS-CoV-2 re-infection: a case report from Qatar
por: AlFehaidi, Alanoud, et al.
Publicado: (2021)

The concordance between the evolutionary trend and the clinical manifestation of the two SARS-CoV-2 variants
por: Hu, Ben, et al.
Publicado: (2021)

Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients
por: Pan, Yunbao, et al.
Publicado: (2020)

Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies
por: Xie, Xiaochun, et al.
Publicado: (2021)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses
por: Zeng, Lei-Ping, et al.
Publicado: (2017)

Structure-based development of human antibody cocktails against SARS-CoV-2
por: Wang, Nan, et al.
Publicado: (2020)

Dynamic changes of serum SARS-CoV-2 antibody levels in COVID-19 patients
por: He, Lu, et al.
Publicado: (2022)

Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2019)

Immune checkpoint: The novel target for antitumor therapy
por: Jiang, Xianghu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bj4g8n2rjpvrr39fhbbcrrihh0